The invention generally relates to computer-based systems for evaluating and marketing clinical trial research centers. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The printable surface further includes a printed data field, including machine-readable marks of digital data encoding a service and a user identity; and a printed border surrounding the printed data field to define an iconic representation.